Find exciting news about our work in breath analysis here. Come back every once in a while.
News
DBI wins the *zünder accelerator award 2023
🚀 Grateful and Thrilled! 💪 The entire DBI Team is beyond excited, that we won the *zünder 🚀 accelerator pitch. We are grateful for the incredible opportunity to attend this special Central Swiss 🇨🇭startup event. It was a truly inspiring moment for our team to feel the excitement, engagement, positive energy and inventiveness of the selected start-ups, the Zünder organisation team and the sponsors.
This achievement is the result of the tireless dedication and hard work of our team, and the unwavering belief in the possibilities of breath analysis. To win this pitch is marking a significant milestone in our journey to elevate breath analysis to new heights.
Read more on our LinkedIn Blog 👉https://www.linkedin.com/feed/update/urn:li:activity:7131648640133013504
Here is the link to the start-up ticker press release 👉 https://www.startupticker.ch/en/news/deep-breath-intelligence-holt-sich-zuender-award-2023
DBI has been selected as finalist by the "zünder accelerator"
Save the Date: 17.11.2023 | 16:00 Uhr 🚀
We are proud being selected as finalist by the "zünder accelerator". 42 great start-ups from central Switzerland participated and all of them would have deserved it! Congratulations to the other finalists.
Celebrate with us at the "zünder startup day" - the highlight event of the Central Switzerland startup community! We look forward to seeing you on November 17, 2023 in Emmenbrücke! Contact us by email/mailto info@dbi.ch or register via the following link https://dbi.ch/en/event-registration17.11.2023 to receive your personal friendship-entry pass.
We are ready to rock the stage! ✨
DBI cordially welcomes its 1st Master Student Kevin
The possibilities of breath analysis in the fields of Therapeutic Drug Monitoring and early disease detection are gaining more and more attention. Breath analysis also fascinates Kevin Lorenzo Marra, our 1st Master Student, who is currently working on his master’s thesis at DBI. Kevin is enrolled at the School of Life Sciences of the University of Applied Sciences Northwestern Switzerland (FHNW). The School of Life Sciences FHNW, located in Muttenz nearby Basel, is one of the largest life sciences locations in Europe. The partnership between FHNW and DBI signifies a meaningful stride in narrowing the gap between academia and industry.
With his background Kevin provides knowledge and hands-on experience in method development and validation for various analytical techniques. We cordially welcome Kevin to our team and are keen to support and accompany him during his internship at DBI.
DBI accelerates the Launch of CE-marked device under IVDD
Exciting news 📢 Deep Breath Intelligence Teams with HTEC Group and Effectum Medical to Accelerate the Launch of CE-marked device under IVDD
DBI is pleased to announce that Emergo will become its authorised DBI-EPIbreath® representative in the European Community, helping Deep Breath Intelligence (DBI) to speed up their time to market and move boundaries in therapeutic drug monitoring (TDM) for people living with epilepsy.
Read more
And the winner is DBI!
Exciting news 📢 DBI has just won the competitive Baracuda Bowl Pitch #SXSW 2023 against four other pre-selected #Healthtech #startups (Italy, USA, 2 x Germany). 🥇 We're thrilled to have come out on top and are excited to see where this win takes us. We believe that our solution for state-of-the-art #breathanalysis revolutionizes precision medicine to the next level and improve people’s health. This victory gives us even more motivation to continue pushing forward.
Find out more about our products and applications.
DBI introduces its first blog, "The Breath Blog"
Breath is fascinating! We can gain so many insights from it to improve people's health. We’re thrilled to have you here for the debut of DBI’s first blog, "The Breath Blog", where we will regularly update you on breath analysis and modern drug therapy management for personal healthcare. Our first series is about people living with epilepsy. But what does that have to do with breath? Read on to find out: “Achieving seizure free in epilepsy”
New publication: Mapping the landscape of lung cancer breath analysis
Read the newest publication of our team-member Felix Schmidt and DBI Co-founder Malcolm Kohler, why the non-invasive, gentle, and fast nature of breath analysis is highly attractive for an improved lung cancer screening algorithm:
Mapping the landscape of lung cancer breath analysis: A scoping review
The full article can be found as well in the lung cancer journal: https://www.lungcancerjournal.info/article/S0169-5002(22)00712-7/fulltext
